Selected research
Industry Research
Olanzapine Orally Disintegrating Tablets Industry Research Report 2026
Market perspective
The global Olanzapine Orally Disintegrating Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Olanzapine Orally Disintegrating Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Olanzapine Orally Disintegrating Tablets market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Olanzapine Orally Disintegrating Tablets market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Olanzapine Orally Disintegrating Tablets include Apotex, Dr. Reddy's Laboratories, PKU HealthCare, QILU Pharmaceutical, Sunshine Lake Pharma, Torrent Pharmaceuticals, Eli Lilly Nederland B.V., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Olanzapine Orally Disintegrating Tablets market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Olanzapine Orally Disintegrating Tablets.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Olanzapine Orally Disintegrating Tablets Market by Company
Apotex
Dr. Reddy's Laboratories
PKU HealthCare
QILU Pharmaceutical
Sunshine Lake Pharma
Torrent Pharmaceuticals
Eli Lilly Nederland B.V.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical
Chengdu Easton Biopharmaceuticals
Olanzapine Orally Disintegrating Tablets Segment by Type
5mg
20mg
15mg
10mg
Olanzapine Orally Disintegrating Tablets Segment by Application
Hospital
Clinic
Others
Olanzapine Orally Disintegrating Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olanzapine Orally Disintegrating Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Olanzapine Orally Disintegrating Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olanzapine Orally Disintegrating Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Olanzapine Orally Disintegrating Tablets companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 20mg
- 15mg
- 10mg
Applications
- Hospital
- Clinic
- Others
Companies covered
- Apotex
- Dr. Reddy's Laboratories
- PKU HealthCare
- QILU Pharmaceutical
- Sunshine Lake Pharma
- Torrent Pharmaceuticals
- Eli Lilly Nederland B.V.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical
- Chengdu Easton Biopharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Olanzapine Orally Disintegrating Tablets by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 5mg
- 2.2.3 20mg
- 2.2.4 15mg
- 2.2.5 10mg
- 2.3 Olanzapine Orally Disintegrating Tablets by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Olanzapine Orally Disintegrating Tablets Breakdown Data by Type
- 3.1 Global Olanzapine Orally Disintegrating Tablets Historic Market Size by Type (2021-2026)
- 3.2 Global Olanzapine Orally Disintegrating Tablets Forecasted Market Size by Type (2027-2032)
4 Olanzapine Orally Disintegrating Tablets Breakdown Data by Application
- 4.1 Global Olanzapine Orally Disintegrating Tablets Historic Market Size by Application (2021-2026)
- 4.2 Global Olanzapine Orally Disintegrating Tablets Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Olanzapine Orally Disintegrating Tablets Market Perspective (2021-2032)
- 5.2 Global Olanzapine Orally Disintegrating Tablets Growth Trends by Region
- 5.2.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Olanzapine Orally Disintegrating Tablets Historic Market Size by Region (2021-2026)
- 5.2.3 Olanzapine Orally Disintegrating Tablets Forecasted Market Size by Region (2027-2032)
- 5.3 Olanzapine Orally Disintegrating Tablets Market Dynamics
- 5.3.1 Olanzapine Orally Disintegrating Tablets Industry Trends
- 5.3.2 Olanzapine Orally Disintegrating Tablets Market Drivers
- 5.3.3 Olanzapine Orally Disintegrating Tablets Market Challenges
- 5.3.4 Olanzapine Orally Disintegrating Tablets Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Olanzapine Orally Disintegrating Tablets Players by Revenue
- 6.1.1 Global Top Olanzapine Orally Disintegrating Tablets Players by Revenue (2021-2026)
- 6.1.2 Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Players (2021-2026)
- 6.2 Global Olanzapine Orally Disintegrating Tablets Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Olanzapine Orally Disintegrating Tablets Head Office and Area Served
- 6.4 Global Olanzapine Orally Disintegrating Tablets Players, Product Type & Application
- 6.5 Global Olanzapine Orally Disintegrating Tablets Manufacturers Established Date
- 6.6 Global Olanzapine Orally Disintegrating Tablets Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 7.2 North America Olanzapine Orally Disintegrating Tablets Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 7.4 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 8.2 Europe Olanzapine Orally Disintegrating Tablets Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 8.4 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 9.2 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 10.2 South America Olanzapine Orally Disintegrating Tablets Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 10.4 South America Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 11.2 Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Apotex
- 12.1.1 Apotex Company Information
- 12.1.2 Apotex Business Overview
- 12.1.3 Apotex Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.1.4 Apotex Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.1.5 Apotex Recent Developments
- 12.2 Dr. Reddy's Laboratories
- 12.2.1 Dr. Reddy's Laboratories Company Information
- 12.2.2 Dr. Reddy's Laboratories Business Overview
- 12.2.3 Dr. Reddy's Laboratories Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.2.4 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.2.5 Dr. Reddy's Laboratories Recent Developments
- 12.3 PKU HealthCare
- 12.3.1 PKU HealthCare Company Information
- 12.3.2 PKU HealthCare Business Overview
- 12.3.3 PKU HealthCare Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.3.4 PKU HealthCare Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.3.5 PKU HealthCare Recent Developments
- 12.4 QILU Pharmaceutical
- 12.4.1 QILU Pharmaceutical Company Information
- 12.4.2 QILU Pharmaceutical Business Overview
- 12.4.3 QILU Pharmaceutical Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.4.4 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.4.5 QILU Pharmaceutical Recent Developments
- 12.5 Sunshine Lake Pharma
- 12.5.1 Sunshine Lake Pharma Company Information
- 12.5.2 Sunshine Lake Pharma Business Overview
- 12.5.3 Sunshine Lake Pharma Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.5.4 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.5.5 Sunshine Lake Pharma Recent Developments
- 12.6 Torrent Pharmaceuticals
- 12.6.1 Torrent Pharmaceuticals Company Information
- 12.6.2 Torrent Pharmaceuticals Business Overview
- 12.6.3 Torrent Pharmaceuticals Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.6.4 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.6.5 Torrent Pharmaceuticals Recent Developments
- 12.7 Eli Lilly Nederland B.V.
- 12.7.1 Eli Lilly Nederland B.V. Company Information
- 12.7.2 Eli Lilly Nederland B.V. Business Overview
- 12.7.3 Eli Lilly Nederland B.V. Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.7.4 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.7.5 Eli Lilly Nederland B.V. Recent Developments
- 12.8 Sun Pharmaceutical Industries Ltd.
- 12.8.1 Sun Pharmaceutical Industries Ltd. Company Information
- 12.8.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 12.8.3 Sun Pharmaceutical Industries Ltd. Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.8.4 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 12.9 Teva Pharmaceutical
- 12.9.1 Teva Pharmaceutical Company Information
- 12.9.2 Teva Pharmaceutical Business Overview
- 12.9.3 Teva Pharmaceutical Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.9.4 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.9.5 Teva Pharmaceutical Recent Developments
- 12.10 Chengdu Easton Biopharmaceuticals
- 12.10.1 Chengdu Easton Biopharmaceuticals Company Information
- 12.10.2 Chengdu Easton Biopharmaceuticals Business Overview
- 12.10.3 Chengdu Easton Biopharmaceuticals Revenue in Olanzapine Orally Disintegrating Tablets Business (2021-2026)
- 12.10.4 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
- 12.10.5 Chengdu Easton Biopharmaceuticals Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst